Anticancer Properties of Novel Rhenium Pentylcarbanato Compounds against MDA-MB-468(HTB-132) Triple Node Negative Human Breast Cancer Cell Lines
Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 3
Abstract
Aim: To study the efficacy of novel rhenium compounds to treat triple node negative breast cancer. Study Design: Six (6) novel rhenium pentycarbanato compounds (PC1-6) were synthesized and triple node negative breast cancer cell lines HTB-132 and Balb/c mouse kidney cell lines were treated with each of them for 48 hours. The results were analyzed by a common trypan blue cell death assay system and statistically analyzed. Place and Duration: The compounds were synthesized, analyzed and evaluated at the Department of Chemistryof Morgan State University, Baltimore, Maryland and the Pharmaceutical Sciences Department of Elizabeth City State University campus of the University of North Carolina system. Methodology: The novel rhenium compounds were synthesized from one-pot reactions of Re2(CO)10 with the corresponding α-diimine ligands in 1-pentanol.The compounds were characterized spectroscopically. The cell lines were cultured by standard cell culture procedure and treated with each of the six compounds in DMSO for 48 hours with a negative control and a DMSO vehicular control along with a cisplatin positive control.The cytotoxicity was evaluated by standard trypan blue assay and the results were statistically analyzed. Results: The trypan blueassay reveals that these compounds have significant cytotoxicity against MDA-MB-468 (HTB-132) triple node negative breast cancer cell lines and are less nephrotoxic than cisplatin. Conclusion: The novel rhenium compounds PC 1-6 can potentially find applications in the treatment of highly malignant triple node negative breast cancer.
Authors and Affiliations
Carl Parson, Valerie Smith, Christopher Krauss, Hirendra N. Banerjee, Jeanette A. Krause, James M. Wachira, Dipak Giri, Angela Winstead, Santosh K. Mandal
Keywords
Related Articles
- EP ID EP344603
- DOI 10.9734/BJPR/2014/4697
- Views 76
- Downloads 0
Evaluation of the Anti-hyperlipidemic Activity of Ethanolic and Aqueous Extracts of Solanum melongena in Wistar Rats
Hyperlipidemia is characterized by hypercholesterolemia and/or hypertriglyceridemia and can lead to obesity, arteroscelerosis and hypertension among others. Although different types of oral hypolipidemic agents are avail...
In-vitro Calcium Oxalate Crystallization Inhibition by Achyranthes aspera L. and Bryophyllum pinnatum Lam
Introduction: Urolithiasis has plagued human kind since antiquity and in the present era, its frequency is increasing with maximum occurrence rate of calcium oxalate stones. Although dramatic changes in the methods of it...
Liposomal Encapsulation of Amikacin Sulphate for Optimizing Its Efficacy and Safety
Aims: The abstract of the current study was to formulate amikacin sulfate in a liposomal formulatiom for enhancing its efficacy and safety. Place and Duration of Study: Pharmaceutical Technology Department, Pharmaceutica...
Medication Errors and Root Causes Analysis: Emerging Views and Practices in King Saud Medical City, Riyadh, Saudi Arabia
Background: Medication errors (MEs) are associated with significant morbidity and mortality, and huge cost worldwide. Medication errors are multifactorial and present in different forms with variable severity. Many tools...
Comparative Quality Control Evaluation of Atenolol Tablets Marketed in Kuala Lumpur, Malaysia
Background: The emergent of many pharmaceutical companies producing their own generic type of drugs after the patent of innovator drugs expired can improve the general healthcare delivery systems as well as decreasing th...